AI assistant
Microbot Medical Inc. — Director's Dealing 2012
Jan 24, 2012
33819_dirs_2012-01-24_34cd01fb-e29f-45f5-928f-5e4057680894.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-01-20
Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-20 | Common Stock | F | 16709 | $0.81 | Disposed | 133313 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6414 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 80,000 restricted stock units, with 40,000 of this grant vesting on each of June 25, 2012 and June 25, 2013 and (2) 11,734 restricted stock units, with 5,867 of this grant vesting on each of May 15, 2012 and May 15, 2013.
F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.